NASDAQ:MRVI

Maravai Lifesciences Holdings Stock Insider Trading

Healthcare > Biotechnology

Buy MRVI

*Your capital is at risk

$6.07

-0.160 (-2.57%)

At Close: Aug 10, 2026

Maravai LifeSciences Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 81.99. In total, the insiders bought 22.14M and sold 930.77K MRVI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	81.99
● Buy	22.14M shares
● Sell	930.77K shares
71% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence Jun 10, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 81.99. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 13, 2025 Buy	Class A Common Stock P-Purchase	Brust Bernd Chief Executive Officer	CEO / President	216 212 Value: $702.7K
Nov 12, 2025 Buy	Class A Common Stock P-Purchase	Brust Bernd Chief Executive Officer	CEO / President	93 358 Value: $299.7K
Nov 11, 2025 Buy	Class A Common Stock P-Purchase	Brust Bernd Chief Executive Officer	CEO / President	157 201 Value: $509.3K
Jul 15, 2025 Sell	Class A Common Stock F-InKind	Leddy Peter Michael See Remarks	Officer	5 154 Value: $13.3K
Jul 15, 2025 Sell	Class A Common Stock F-InKind	Leddy Peter Michael See Remarks	Officer	5 154 Value: $13.3K
Jul 10, 2025 Buy	Class A Common Stock G-Gift	Lucier Gregory T Director	Director	89 139 Value: $257.6K
Jul 10, 2025 Sell	Class A Common Stock G-Gift	Lucier Gregory T Director	Director	89 139 Value: $0
Jul 10, 2025 Sell	Class A Common Stock G-Gift	Lucier Gregory T Director	Director	89 139 Value: $0
Jul 10, 2025 Buy	Class A Common Stock G-Gift	Lucier Gregory T Director	Director	89 139 Value: $257.6K
Jun 30, 2025 Buy	Performance Stock Units A-Award	Asarpota Rajesh Chief Financial Officer	C-Suite Officer	750 000 Value: $1.81M
Jun 30, 2025 Buy	Class A Common Stock A-Award	Asarpota Rajesh Chief Financial Officer	C-Suite Officer	500 000 Value: $1.21M
Jun 30, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Asarpota Rajesh Chief Financial Officer	C-Suite Officer	333 333 Value: $803.3K
Jun 30, 2025 Buy	Common Stock J-Other	Asarpota Rajesh Officer	Officer	0 Value: $0
Jun 30, 2025 Buy	Common Stock J-Other	Asarpota Rajesh Officer	Officer	0 Value: $0
Jun 30, 2025 Buy	Employee Stock Option (Right to Buy) A-Award	Asarpota Rajesh Chief Financial Officer	C-Suite Officer	333 333 Value: $803.3K
Jun 30, 2025 Buy	Class A Common Stock A-Award	Asarpota Rajesh Chief Financial Officer	C-Suite Officer	500 000 Value: $1.21M
Jun 30, 2025 Buy	Performance Stock Units A-Award	Asarpota Rajesh Chief Financial Officer	C-Suite Officer	750 000 Value: $1.81M
Jun 16, 2025 Buy	Class A Common Stock A-Award	Daverman Benjamin James Director	Director	89 139 Value: $192.5K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Gray Susannah Director	Director	89 139 Value: $192.5K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Marker Luke Joseph Director	Director	89 139 Value: $192.5K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Lucier Gregory T Director	Director	89 139 Value: $192.5K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Prahalad Murali Director	Director	89 139 Value: $192.5K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Cunningham Sean Laurence Director	Director	89 139 Value: $192.5K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Eckert R Andrew Director	Director	231 481 Value: $500.0K
Jun 16, 2025 Buy	Class A Common Stock A-Award	Mihas Constantine S Director	Director	89 139 Value: $192.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MARAVAI LIFESCIENCES HOLDINGS, INC.

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the productio...

Read Full Profile Here